Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):54-56
This study was performed to evaluate a potential of ribavirin for inhibiting Batai virus replication in vitro. Ribavirin manufactured by ICN Switzerland AG (Switzerland) was used for the study. The drug and specific immune ascitic fluid were added to …